A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders
Open Access
- 13 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15, 709436
- https://doi.org/10.3389/fnins.2021.709436
Abstract
Vagus nerve stimulation (VNS) is an established form of neuromodulation with a long history of promising applications. Earliest reports of VNS in the literature date to the late 1800’s in experiments conducted by Dr. James Corning. Over the past century, both invasive and non-invasive VNS have demonstrated promise in treating a variety of disorders, including epilepsy, depression, and post-stroke motor rehabilitation. As VNS continues to rapidly grow in popularity and application, the field generally lacks a consensus on optimum stimulation parameters. Stimulation parameters have a significant impact on the efficacy of neuromodulation, and here we will describe the longitudinal evolution of VNS parameters in the following categorical progression: (1) animal models, (2) epilepsy, (3) treatment resistant depression, (4) neuroplasticity and rehabilitation, and (5) transcutaneous auricular VNS (taVNS). We additionally offer a historical perspective of the various applications and summarize the range and most commonly used parameters in over 130 implanted and non-invasive VNS studies over five applications.Keywords
Funding Information
- National Institutes of Health (5P20GM109040-08, 1R43DA050360-01, 5P2CHD086844-05, 1P50DA046373-01A1)
This publication has 122 references indexed in Scilit:
- CNS BOLD fMRI Effects of Sham-Controlled Transcutaneous Electrical Nerve Stimulation in the Left Outer Auditory Canal – A Pilot StudyBrain Stimulation, 2013
- Transcutaneous vagus nerve stimulation (t‐VNS) in pharmacoresistant epilepsies: A proof of concept trialEpilepsia, 2012
- Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorderBrain Stimulation, 2012
- Comparison of ΔFosB Immunoreactivity Induced by Vagal Nerve Stimulation with That Caused by Pharmacologically Diverse AntidepressantsThe Journal of pharmacology and experimental therapeutics, 2012
- Transcutaneous Vagus Nerve Stimulation: Retrospective Assessment of Cardiac Safety in a Pilot StudyFrontiers in Psychiatry, 2012
- Reversing pathological neural activity using targeted plasticityNature, 2011
- Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampusInternational Journal of Neuropsychopharmacology, 2009
- Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolismNeuroImage, 2008
- Post-training Unilateral Vagal Stimulation Enhances Retention Performance in the RatNeurobiology of Learning and Memory, 1995
- Feasibility and Safety of Vagal Stimulation In Monkey ModelEpilepsia, 1990